Rodman & Renshaw Initiates Coverage On Coya Therapeutics with Buy Rating, Announces Price Target of $18
Portfolio Pulse from Benzinga Newsdesk
Rodman & Renshaw has initiated coverage on Coya Therapeutics (NASDAQ:COYA) with a Buy rating and set a price target of $18.
June 13, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rodman & Renshaw has initiated coverage on Coya Therapeutics with a Buy rating and set a price target of $18.
The initiation of coverage with a Buy rating and a price target of $18 by Rodman & Renshaw is likely to positively impact Coya Therapeutics' stock price in the short term. Analyst ratings and price targets are significant indicators for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100